Immunostaining of paraffin sections verified the reduced pERK in inhibitor-treated tumors and showed a significant reduction in the percentage of Ki67+ tumor cells in all treatment groups when compared to vehicle controls; there was no significant difference with the combination therapy (Fig 1E and F). This evidence concerns the gene MKI67 and neoplasm.